These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7824873

  • 1. Effect of ursodeoxycholic acid on hepatic cholesterol metabolism.
    Einarsson K.
    Scand J Gastroenterol Suppl; 1994; 204():19-23. PubMed ID: 7824873
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones.
    Okamoto S, Nakano K, Kosahara K, Kishinaka M, Oda H, Ichimiya H, Chijiiwa K, Kuroki S.
    J Gastroenterol; 1994 Feb; 29(1):47-55. PubMed ID: 8199696
    [Abstract] [Full Text] [Related]

  • 4. Intestinal resection and ursodeoxycholic acid: effect on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl-CoA:cholesterol acyltransferase activities in the rat.
    Molina MT, Ruiz-Gutierrez V, Vazquez CM.
    Res Exp Med (Berl); 1997 Feb; 196(6):381-7. PubMed ID: 9089887
    [Abstract] [Full Text] [Related]

  • 5. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N, Carubbi F, Bozzoli M, Bertolotti M, Farah I, Rosi A, Carulli N.
    Ital J Gastroenterol; 1994 Feb; 26(6):287-93. PubMed ID: 7949265
    [Abstract] [Full Text] [Related]

  • 6. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
    Angelin B, Ewerth S, Einarsson K.
    J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment.
    Sahlin S, Ahlberg J, Reihnér E, Ståhlberg D, Einarsson K.
    Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340
    [Abstract] [Full Text] [Related]

  • 8. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS, Salen G, Shefer S.
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [Abstract] [Full Text] [Related]

  • 9. Effect of pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on hepatic cholesterol 7 alpha-hydroxylase, acyl-coenzyme A: cholesterol acyltransferase, and bile lipid secretion in the hamster with intact enterohepatic circulation.
    Hayashi K, Noshiro M, Kurushima H, Kuga Y, Nomura S, Ohkura Y, Ohtani H, Kurokawa J, Tanaka K, Yasunobu Y.
    Atherosclerosis; 1994 Dec; 111(2):183-9. PubMed ID: 7718020
    [Abstract] [Full Text] [Related]

  • 10. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B.
    N Engl J Med; 1990 Jul 26; 323(4):224-8. PubMed ID: 2114543
    [Abstract] [Full Text] [Related]

  • 11. Effects of perturbations in hepatic free and esterified cholesterol pools on bile acid synthesis, cholesterol 7 alpha-hydroxylase, HMG-CoA reductase, acyl-CoA:cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase.
    Grogan WM, Bailey ML, Heuman DM, Vlahcevic ZR.
    Lipids; 1991 Nov 26; 26(11):907-14. PubMed ID: 1805095
    [Abstract] [Full Text] [Related]

  • 12. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC, Zhao Z, Keller RK.
    Arch Biochem Biophys; 1994 Jun 26; 311(2):277-85. PubMed ID: 7911291
    [Abstract] [Full Text] [Related]

  • 13. Early morphologic and enzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids.
    Shefer S, Zaki FG, Salen G.
    Hepatology; 1983 Jun 26; 3(2):201-8. PubMed ID: 6832710
    [Abstract] [Full Text] [Related]

  • 14. Regulation of ovarian cholesterol metabolism: control of 3-hydroxy-3-methylglutaryl coenzyme A reductase and acyl coenzyme A:cholesterol acyltransferase.
    Schuler LA, Toaff ME, Strauss JF.
    Endocrinology; 1981 Apr 26; 108(4):1476-86. PubMed ID: 7472277
    [Abstract] [Full Text] [Related]

  • 15. Altered lipid metabolism in apolipoprotein E-deficient mice does not affect cholesterol balance across the liver.
    Kuipers F, van Ree JM, Hofker MH, Wolters H, In't Veld G, Havinga R, Vonk RJ, Princen HM, Havekes LM.
    Hepatology; 1996 Jul 26; 24(1):241-7. PubMed ID: 8707269
    [Abstract] [Full Text] [Related]

  • 16. Hepatic cholesterol metabolism in estrogen-treated men.
    Angelin B, Olivecrona H, Reihnér E, Rudling M, Ståhlberg D, Eriksson M, Ewerth S, Henriksson P, Einarsson K.
    Gastroenterology; 1992 Nov 26; 103(5):1657-63. PubMed ID: 1426886
    [Abstract] [Full Text] [Related]

  • 17. Hepatic cholesterol metabolism in human obesity.
    Ståhlberg D, Rudling M, Angelin B, Björkhem I, Forsell P, Nilsell K, Einarsson K.
    Hepatology; 1997 Jun 26; 25(6):1447-50. PubMed ID: 9185766
    [Abstract] [Full Text] [Related]

  • 18. Lithogenic diet and gallstone formation in mice: integrated response of activities of regulatory enzymes in hepatic cholesterol metabolism.
    Reihnér E, Ståhlberg D.
    Br J Nutr; 1996 Nov 26; 76(5):765-72. PubMed ID: 8958009
    [Abstract] [Full Text] [Related]

  • 19. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
    Sauter GH, Thiessen K, Parhofer KG, Jüngst C, Fischer S, Jüngst D.
    Digestion; 2004 Nov 26; 70(2):79-83. PubMed ID: 15375335
    [Abstract] [Full Text] [Related]

  • 20. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND, Liang K, Azad H.
    J Pharmacol Exp Ther; 2000 Aug 26; 294(2):778-83. PubMed ID: 10900260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.